Merck Vaccine Sales Drop as US Declines Strike Another Pharma

While the company’s sales outlook was otherwise rosy, Merck took sales hits on Gardisil, Proquad, Varivax and Vaxneuvance.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top